Deep Brain Stimulation Portfolio

Infinity™ DBS system IPGs and patient programming device with wireless Bluetooth® technology

Portfolio Overview

  • Advancing technology to help patients gain control of on-times and symptom-free times
  • Providing innovations for device performance, proprietary directional lead technology and mobile programming
  • Investing in research for future innovation


Focused on improving patient outcomes and experience, we developed our DBS solutions with input from physicians like you. 

Precisely Customize DBS Therapy

The St. Jude Medical Infinity™ DBS system—with a revolutionary directional lead and wireless iOS software—can now help you maximize outcomes for your patients.

See the implant procedure, how the system provides precise therapy and the system’s easy, advanced wireless programming.

Precise Directional Lead Technology

The latest in DBS lead technology, our segmented lead offers more flexibility to help you maximize outcomes, and is easy to program using an intuitive touch screen.

A computational modeling study confirmed that our latest directional lead gives you the ability to precisely steer current towards desired structural areas, while potentially avoiding stimulation to structures or regions that may cause side effects for your patients.

Learn more about the directional lead for the St. Jude Medical Infinity™ DBS system.

Numbered diagram of Infinity™ DBS system directional lead for deep brain stimulation therapy
Infinity™ Deep Brain Stimulation system showing patient and clinician programmers

Streamline Therapy With a Wireless iOS Software Mobile Platform

No wands. No wires. With the first and only iOS DBS programming platform in the world,3 the St. Jude Medical Infinity™ DBS system provides you and your patients with a more convenient, intuitive and discrete approach to DBS therapy.

Learn more about how you can streamline and customize therapy management with the St. Jude Medical Infinity™ DBS system.

Enhanced Patient Comfort

With the smallest bilateral conventional cell IPG on the market,4 the St. Jude Medical Infinity™ DBS system helps improve your patients’ comfort to support their lifestyles.

The St. Jude Medical Infinity™ DBS IPG has the lowest skin pressure of all conventional cell IPGs4,5 and zero fractures have been reported for our eXtend™ lead extensions technology since international regional market entry four years ago.*,6

Zero fractures have been reported in four years (post-market) with our eXtend™ lead extensions technology.3

Infographic describes that parkinson

Clinical Research for DBS Therapy

Clinical evidence supports DBS therapy as an effective way to control symptoms in patients with Parkinson’s disease and essential tremor.

  • For Parkinson’s disease patients, DBS therapy can improve “on time” without dyskinesias or with nonbothersome dyskinesias, and sustain improvement up to 12 months.7
  • Of essential tremor patients, 9 out of 10 were satisfied or very satisfied with [a St. Jude Medical™] DBS system's ability to control their symptoms.8
See Clinical Evidence

Transforming the Treatment of Movement Disorders

Movement disorders such as Parkinson’s disease and essential tremor take devastating emotional and economic tolls on millions of patients and their families.9,10 At Abbott, we work with movement disorder specialists to develop therapies that deliver targeted symptom control and improve the patient experience.

Learn about our approach to movement disorders.

Labeled diagram drawing of the brain


*Converts Medtronic systems that utilize IS-1 extensions (Kinetra™ and Soletra™ IPGs)
Apple is a trademark of Apple, Inc. Bluetooth is a registered trademark of Bluetooth SIG, Inc. iOS is a trademark of Cisco Technology, Inc. Kinetra and Soletra are trademarks of Medtronic, Inc.
1. St. Jude Medical. St. Jude Medical Infinity™ IPG Size Related Claims Memo, Zinc # SJM-INF-0815-0007
2. Okun, M., Gallo, B. V., Mandybur, G., Jagid, J., Foote, K. D., Revilla, F. J., ... Tagliati, M. (2012). Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: An open-label randomized controlled trial. The Lancet Neurology, 11(2), 140-149.
3. St. Jude Medical. St. Jude Medical Infinity™ IPG Programming Options Claims Memo, Zinc # SJM-INF-0815-0010.
4. St. Jude Medical. (2015). St. Jude Medical Infinity™ IPG Clinician’s Manual. Plano, TX.
5. St. Jude Medical. St. Jude Medical Infinity™ Coiled Extensions No Fractures Claim Memo, Zinc # SJM-INF-0815-0012.
6. St. Jude Medical. (2012). Parkinson’s Disease Study.
7. St. Jude Medical. (2014). Tremor Study Final Report, Table 24.
8. European Parkinson’s Disease Association. Prevalence of Parkinson’s disease Accessed September 3, 2015.
9. Dystonia Europe—Connecting People for Dystonia. Dystonia. Accessed September 3, 2015.

Orange 24 surrounded by headset, represents "Place an order"

Contact Customer Service

Our customer service experts can help with your product orders or questions.